ALEXANDRIA, Va., March 12 -- United States Patent no. 12,247,320, issued on March 11, was assigned to Brandeis University (Waltham, Mass.).
"Multivalent glycopeptides that tightly bind to carbohydrate-binding monoclonal antibody family PGT128" was invented by Isaac J. Krauss (Needham Heights, Mass.), Satoru Horiya (Somerville, Mass.) and Jennifer Bailey (Waltham, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a glycopeptide that includes one or more modified amino acid residues having a sidechain comprising a monosaccharide or an oligosaccharide, wherein the glycopeptide binds specifically to a carbohydrate-binding monoclonal antibody from PGT128 family, preferably with an affi...